114 related articles for article (PubMed ID: 8209016)
1. Color Doppler imaging of liver metastases. The value phase-III of a US contrast agent: SH U 508 A (Levovist) Schering.
Campani R; Bozzini A; Calliada F; Bottinelli O; Anguissola R; Conti MP; Corsi G
Radiol Med; 1994 May; 87(5 Suppl 1):32-40. PubMed ID: 8209016
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of SH U 508 A (Levovist) in color Doppler ultrasonography of hepatocellular carcinoma vascularization.
Angeli E; Carpanelli R; Crespi G; Zanello A; Sironi S; Del Maschio A
Radiol Med; 1994 May; 87(5 Suppl 1):24-31. PubMed ID: 8209014
[TBL] [Abstract][Full Text] [Related]
3. Color Doppler ultrasonography in the differential diagnosis of focal hepatic lesions. The SH U 508 A (Levovist) experience.
Maresca G; Barbaro B; Summaria V; De Gaetano AM; Salcuni M; Mirk P; Marano P
Radiol Med; 1994 May; 87(5 Suppl 1):41-9. PubMed ID: 8209017
[TBL] [Abstract][Full Text] [Related]
4. [Hepatic focal lesions: role of color Doppler ultrasonography with contrast media].
Pennisi F; Farina R; Politi G; Lombardo R; Puleo S
Radiol Med; 1998 Dec; 96(6):579-87. PubMed ID: 10189920
[TBL] [Abstract][Full Text] [Related]
5. [Pulse inversion ultrasonography with ultrasonography contrast media (levovist) in the evaluation of hepatic metastasis].
Giovagnoni A; Martegani A; Aiani L; Ligabue G; Romagnoli R; Del Favero C
Radiol Med; 2001 Mar; 101(3):111-7. PubMed ID: 11402947
[TBL] [Abstract][Full Text] [Related]
6. Color doppler ultrasound of liver lesions: signal enhancement after intravenous injection of the ultrasound contrast agent Levovist.
Ernst H; Hahn EG; Balzer T; Schlief R; Heyder N
J Clin Ultrasound; 1996 Jan; 24(1):31-5. PubMed ID: 8655665
[TBL] [Abstract][Full Text] [Related]
7. The Italian experience with SH U 508 A (Levovist) in breast disease.
Spreafico C; Lanocita R; Frigerio LF; Di Tolla G; Garbagnati F; Milella M; Marchianò A; Piragine G; Damascelli B
Radiol Med; 1994 May; 87(5 Suppl 1):59-64. PubMed ID: 8209019
[TBL] [Abstract][Full Text] [Related]
8. Color Doppler flow imaging of renal disease. Value of a new intravenous contrast agent: SH U 508 A (Levovist).
Filippone A; Muzi M; Basilico R; Di Giandomenico V; Trapani AR; Bonomo L
Radiol Med; 1994 May; 87(5 Suppl 1):50-8. PubMed ID: 8209018
[TBL] [Abstract][Full Text] [Related]
9. Feasibility study of an ultrasound contrast agent (levovist) in color Doppler imaging of liver neoplasms.
Jiang Y; Dai Q; Liu J; Zhang J; Chang X; Cai S; Tan L
Chin Med Sci J; 1999 Sep; 14(3):167-9. PubMed ID: 12903818
[TBL] [Abstract][Full Text] [Related]
10. Characterization of focal hepatic lesions in cirrhotic patients by Pulse Inversion Harmonic Imaging US contrast specific technique with Levovist.
Quaia E; Forgács B; Calderan L; Bertolotto M; Pozzi Mucelli R
Radiol Med; 2002 Oct; 104(4):285-94. PubMed ID: 12569309
[TBL] [Abstract][Full Text] [Related]
11. [Stimulated acoustic emissions with the ultrasound contrast medium levovist: a clinically useful contrast effect with liver-specific properties].
Albrecht T; Blomley MJ; Heckemann RA; Cosgrove DO; Jayaram V; Butler-Barnes J; Eckersley RJ; Hoffmann CW; Bauer A
Rofo; 2000 Jan; 172(1):61-7. PubMed ID: 10719465
[TBL] [Abstract][Full Text] [Related]
12. [Ultrasonography contrast media Levovist and power Doppler in the study of the breast. Methodology, vascular morphology and automatic enhancement quantification with wash-in and wash-out curves].
Menna S; Di Virgilio MR; Burke P
Radiol Med; 1999 Jun; 97(6):472-8. PubMed ID: 10478204
[TBL] [Abstract][Full Text] [Related]
13. Efficacy SH U 508 A (Levovist) as blood pool enhancer in the Doppler evaluation of multiple vascular regions.
Schwarz KQ; Bezante GP; Becher H; Schimpfky C; Vorwerk D; Bogdahn U; Schlief R
Radiol Med; 1994 May; 87(5 Suppl 1):3-14. PubMed ID: 8209015
[TBL] [Abstract][Full Text] [Related]
14. [Role of color Doppler ultrasonography with contrast media in the monitoring of hepatocarcinoma after intralesional treatment].
Pennisi F; Farina R; Ponzio R; Fragione D; Lombardo R; Azzarello G; Puleo S
Radiol Med; 1999 Mar; 97(3):144-7. PubMed ID: 10363055
[TBL] [Abstract][Full Text] [Related]
15. [Doppler color ultrasonography with contrast media in the study of eye and orbit neoplasms].
Coppola V; Vallone G; Verrengia D; Alfinito M; Molese V; Brunese L; Smaltino F
Radiol Med; 1997 Apr; 93(4):367-73. PubMed ID: 9244912
[TBL] [Abstract][Full Text] [Related]
16. A multicenter, prospective, open label, randomized, controlled phase IIIb study of SH U 508 a (Levovist) for Doppler signal enhancement in the portal vascular system.
Gebel M; Caselitz M; Bowen-Davies PE; Weber S
Ultraschall Med; 1998 Aug; 19(4):148-56. PubMed ID: 9816618
[TBL] [Abstract][Full Text] [Related]
17. Sonographic evaluation of focal nodular hyperplasias (FNH) of the liver with a transpulmonary galactose-based contrast agent (Levovist).
Uggowitzer M; Kugler C; Gröll R; Mischinger HJ; Stacher R; Fickert P; Weiglein A
Br J Radiol; 1998 Oct; 71(850):1026-32. PubMed ID: 10211062
[TBL] [Abstract][Full Text] [Related]
18. [Vascularization patterns in focal liver lesions: comparison of plain and signal-enhanced amplitude-modulated color duplex ultrasonography].
Hosten N; Steger W; Bechstein WO; Zendel WJ; Venz S; Lemke AJ; Weber S; Vogl TJ; Felix R
Rofo; 1997 Jun; 166(6):507-13. PubMed ID: 9273003
[TBL] [Abstract][Full Text] [Related]
19. Ultrasound contrast agent Levovist in colour Doppler sonography of hepatocellular carcinoma in Chinese patients.
Khong PL; Chau MT; Fan ST; Leong LL
Australas Radiol; 1999 May; 43(2):156-9. PubMed ID: 10901894
[TBL] [Abstract][Full Text] [Related]
20. Characterization of focal liver lesions in real time using harmonic imaging with high mechanical index and contrast agent levovist.
Migaleddu V; Virgilio G; Turilli D; Conti M; Campisi G; Canu N; Sirigu D; Vincentelli I
AJR Am J Roentgenol; 2004 Jun; 182(6):1505-12. PubMed ID: 15149997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
